Code | 41001 | ||||||||||
MA number | EU/1/01/185/035 | ||||||||||
Product Form: | sol inj 1x0,5 ml/20 µg (napl.skl.striek.- neblistr.bal.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Amgen Europe B.V., Netherland | ||||||||||
Therapeutic Class: | 12 - ANTIANAEMICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Subcutaneous and intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 08.06.2001 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 30.06.2021 |